Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

Building partnerships through divestments

As we near the end of our partnerships & licensing focus month, Cynthia Tso and Nigel Borshell look at a new emerging business model – building partnerships through divestments. Over the last decade, big pharma companies have faced up to the challenge of a changing business model. No longer can...

Articles

A roundup of ‘Social pharma faces’ 2012

Rebecca Aris provides a roundup of the ‘Social pharma faces’ interview series published in 2012, in which we interviewed digital healthcare thought leaders, and highlights some common advice from the experts. Throughout 2012 we’ve spoken with eight experts in the digital healthcare space as part of our ‘Social pharma faces’ series. These experts have...

Articles

Ten stages to a successful pharma partnership

Jean-Louis Roux Dit Buisson shares with us the ten stages to a successful pharma partnership, to coincide with our partnerships & licensing focus month. If you come from a start-up or small biotech, there are chances that negotiating a license, an acquisition, or...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital